Supreme Court Panel Report on Repealed Farm Laws
On 19th March, 2021, a Supreme Court-appointed panel to study the three farm laws, which was scrapped by Parliament in November 2021, submitted its report to the apex court.
- The bilateral interactions of the Committee with the stakeholders demonstrated that only 13.3 percent of the stakeholders were not in favour of the farm laws.
- Around 85.7 percent of the farmer organizations, representing more than 3.3 crore farmers supported the laws.
Broad Recommendations
Abolish Essential Commodity Act (ECA)
- It recommended abolishing the Essential Commodity Act (ECA).
- Or, as an alternative, it wanted the Centre to “substantially liberalize its provisions.” ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Bharat Cleantech Manufacturing Platform
- 2 Five New Industrial Clusters from India join WEF Initiative
- 3 Logistics Ease Across Different States (LEADS) 2024 Report
- 4 Team Initiative:Boosting Digital Commerce for MSMEs
- 5 Diamond Imprest Authorization Scheme
- 6 National Critical Minerals Mission
- 7 Mutual Credit Guarantee Scheme for MSMEs
- 8 National Manufacturing Mission
- 9 Financialisation of the Economy
- 10 Undercapitalization of Indian Debt Market

- 1 Carbon-Neutral Agriculture
- 2 Rupee-Rouble Trade Agreement
- 3 RBI Removes Pricing Caps for Microfinance Lenders
- 4 Framework for Geo-tagging of Payment System Touch Points
- 5 National Land Monetisation Corporation
- 6 Brahmaputra (NW2) gets connected with Ganga (NW1)
- 7 Virtual Smart Grid Knowledge Centre
- 8 Raising and Accelerating MSME Performance
- 9 Scheme for Strengthening of Pharmaceutical Industry
- 10 Coastal Economic Zone
- 11 National Pharmaceutical Pricing Authority